Nicholas Polytaridis works as Sr. Manager of Corporate Development at Dexcom, Inc., a leading medical device company that designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people living with diabetes. In his role, Nicholas focuses on driving business partnerships, strategic investments, and other corporate growth initiatives for the company.
Nicholas earned a Bachelor’s degree in Bioengineering from the University of California, San Diego, where his personal passion for improving human lives was forged. This set the stage for his entry into the field of medical devices where he spent the last 20 years contributing to companies such as Biosite (now owned by Abbott), Gen-Probe (now owned by Hologic), and Dexcom. In 2019, Nicholas earned his Executive MBA degree from the UCLA Anderson School of Management. For his capstone project Nicholas and his team spent six months consulting with a non-profit medical device manufacturer that was developing neonatal CPAP breathing-assist devices for medically underserved areas in India and East Africa. From this experience, he developed an interest and passion for improving the standard-of-living in third-world nations. Nicholas is a talented young professional, a father of three children, and a master ‘organizer’ in both of these roles. Quench and Connect will benefit from his energy as a member of the Board of Directors, particularly from his skills in strategic planning.